196 related articles for article (PubMed ID: 26883254)
1. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
2. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.
Liu H; Shen Z; Wang X; Zhang H; Qin J; Qin X; Xu J; Sun Y
Tumour Biol; 2016 Mar; 37(3):3285-93. PubMed ID: 26438062
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.
Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J
Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634
[TBL] [Abstract][Full Text] [Related]
5. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.
Cao Y; Liu H; Zhang H; Lin C; Li R; Wu S; Li H; He H; Zhang W; Xu J
Oncotarget; 2017 Mar; 8(12):20328-20339. PubMed ID: 27780937
[TBL] [Abstract][Full Text] [Related]
6. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
7. High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.
Li R; Zhang H; Liu H; Lin C; Cao Y; Zhang W; Shen Z; Xu J
Oncotarget; 2016 Apr; 7(17):23909-18. PubMed ID: 26992207
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
9. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
[TBL] [Abstract][Full Text] [Related]
11. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
13. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.
He H; Shen Z; Zhang H; Wang X; Tang Z; Xu J; Sun Y
Br J Cancer; 2014 Apr; 110(8):2021-9. PubMed ID: 24619076
[TBL] [Abstract][Full Text] [Related]
15. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy.
Liu H; Zhang H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
Medicine (Baltimore); 2016 Mar; 95(9):e2675. PubMed ID: 26945355
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.
Lin C; Liu H; Zhang H; He H; Li H; Shen Z; Qin J; Qin X; Xu J; Sun Y
Oncotarget; 2016 Aug; 7(31):49281-49288. PubMed ID: 27351230
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.
Wang X; He H; Zhang H; Chen W; Ji Y; Tang Z; Fang Y; Wang C; Liu F; Shen Z; Qin J; Zhu Y; Liu H; Xu J; Gu J; Qin X; Sun Y
Cancer Sci; 2013 Feb; 104(2):185-93. PubMed ID: 23107376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]